BA
MDCO

Boston Advisors’s Medicines Co MDCO Stock Holding History

Boston Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11,117
Closed -$316K – 606
2014
Q1 		$316K Sell
11,117
-43,360
-80% -$1.43M 0.01% 451
2013
Q4 		$2.1M Buy
54,477
+44,375
+439% +$1.59M 0.1% 188
2013
Q3 		$339K Buy
10,102
+3,252
+47% +$104K 0.02% 383
2013
Q2 		$211K Buy
+6,850
New +$229K 0.01% 509

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Boston Advisors's MDCO Position: Q2 2014 in Review

Boston Advisors sold out of Medicines Co (MDCO) in Q2 2014, closing a stake of 11,117 shares — an estimated $316K sold.

Boston Advisors first reported a position in MDCO in Q2 2013 and held it in 4 quarters. The position peaked at $2.1M in Q4 2013. 152 funds tracked by Wall St. Rank hold MDCO as of Q2 2014.

  • Boston Advisors reported no remaining Medicines Co position as of Q2 2014 after selling out during the quarter.
  • Boston Advisors sold 11,117 Medicines Co shares in Q2 2014, an estimated $316K.
  • Boston Advisors first reported a position in Medicines Co in Q2 2013 and held it in 4 quarters.
  • Boston Advisors's Medicines Co position peaked at $2.1M in Q4 2013.
  • 152 funds tracked by Wall St. Rank held Medicines Co as of Q2 2014.

Based on Boston Advisors's 13F filing for Q2 2014, filed 23 Jul 2014.